Javier Martin Moreiras

Interventional cardiologist / Cardiologist
University Hospital of Salamanca - Salamanca, Spain

Latest contributions

Challenges of multivessel disease in ACS

21 May 2026 – From EuroPCR 2026

Dedicated to the challenges of multivessel disease in acute coronary syndrome (ACS), this session explores strategies to identify culprit versus non-culprit lesions and plan multivessel revascularisation using physiology, intravascular imaging, and artificial intelligence. It further discusses the timing considerations for revascularisation, whether ad-hoc or staged, illustrated...

Left main interventions: pushing the boundaries

21 May 2026 – From EuroPCR 2026

Examine contemporary strategies for distal left main bifurcation disease treatment, including debates on complex bifurcation and high-risk PCI approaches. The session emphasizes the critical role of coronary imaging in guiding decision-making and showcases clinical cases illustrating management of left main interventions under challenging conditions.

Fighting intracardiac masses

21 May 2026 – From EuroPCR 2026

This session focuses on the percutaneous management of intracardiac masses, presenting innovative approaches such as angiovac-assisted vegetation removal, management of mechanical mitral valve complications, and treatment options for right ventricular tumors. It also evaluates the emerging role of percutaneous therapies in infective endocarditis involving TAVI valves...

Plaque modification in different lesions types: nodular, long lesions, tortuous lesions, bifurcations

28 Feb 2026 – From Euro4C Annual Meeting 2026

Explore advanced plaque modification strategies tailored to diverse lesion types such as nodular, long, tortuous lesions, and bifurcations. Delve into approaches for managing under-expanded stents and calcified nodules, supported by evidence including results from the French orbital atherectomy registry.

Plaque modification in different lesions types: nodular, long lesions, tortuous lesions, bifurcations

Double jeopardy: coronary disease in patients undergoing TAVI

17 May 2022 – From EuroPCR 2022

Through the presentation of real-life clinical cases, this session will allow you to discover the use of ALLEGRA for valve-in-valve TAVI, understand the management of coronary artery disease in TAVI patients, better detect when and how to protect coronary arteries during TAVI, or even learn how...

Double jeopardy: coronary disease in patients undergoing TAVI